CLYM Climb Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$10,94
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,54rendah 52m
$18,33tinggi 52m
Kapitalisasi Pasar (MRQ)
$628M
P/E
-12.4
EPS
$-0.88
lencana Anda
Rentang 52M
$2–$18
Peringkat Analis
STRONG BUY
Target Harga
$28
P/E
-12.4
ROE
-34.6%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CLYM Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$10.94
Kapitalisasi Pasar (MRQ)
$628M
P/E
-12.4
EPS
$-0.88
ROE
-34.6%
Rentang 52M
$2–$18
CLYM Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-0.882021-12-31 → 2025-12-31
Arus Kas Bebas$-55M2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CLYM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -12.4rata-rata 5T ≈-2.5 | ≈-2.5 | · | · | |
| P/B (MRQ) | 2.6rata-rata 5T ≈1.0 | ≈1.0 | 3.2 | Nilai wajar | |
| Price / FCF (Harga / FCF) | -9.6 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -9.6rata-rata 5T ≈-5.4 | ≈-5.4 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.3rata-rata 5T ≈1.0 | ≈1.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CLYM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -31.1%rata-rata 5T ≈-38.4% | ≈-38.4% | -31.1% | Sejajar | |
| ROE | -34.6%rata-rata 5T ≈-32.7% | ≈-32.7% | -34.6% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CLYM | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 31.5rata-rata 5T ≈23.3 | ≈23.3 | 8.0 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 14.5rata-rata 5T ≈22.0 | ≈22.0 | 5.2 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-14.0%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 18, 2026 | $-0.18 | $-0.22 | 17.4% |
| 31 Maret 2026 | Mei 19, 2026 | $-0.20 | $-0.27 | 26.5% |
| 31 Des. 2025 | $-0.26 | $-0.20 | -29.4% | |
| 30 Sep. 2025 | $-0.19 | $-0.15 | -27.0% | |
| 30 Juni 2025 | $-0.13 | $-0.19 | 31.1% | |
| 31 Maret 2025 | $-0.31 | $-0.15 | -102.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $14M | $15M | $26M | $23M | $9M | |
| SG&A Expense | $21M | $16M | $25M | $19M | $12M | $2M | |
| Operating Expenses | $68M | $82M | $40M | $45M | $36M | $21M | |
| Operating Income | $-68M | $-82M | $-40M | $-45M | $-36M | $-21M | |
| Interest Income | $8M | $8M | $5M | · | · | · | |
| Other Non-op | $8M | $8M | $5M | $-109.0K | $-12M | $257.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M | $-21M | |
| EPS (Basic) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| EPS (Diluted) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| Shares (Basic) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | · | |
| Shares (Diluted) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | 2,187,813 | |
| EBITDA | $-68M | $-82M | · | $-45M | $-36M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $87M | $93M | $44M | $47M | $20M | |
| Short-term Investments | $65M | $64M | $14M | $80M | $90M | $0 | |
| Prepaid Expense | $5M | $4M | $3M | $11M | $12M | $2M | |
| Current Assets | $106M | $155M | $110M | $134M | $148M | $22M | |
| PP&E (Net) | $288.0K | $199.0K | · | · | · | · | |
| Other Non-current Assets | $2M | $16.0K | $15.0K | $128.0K | $70.0K | $3M | |
| Total Assets | $168M | $217M | $110M | $135M | $173M | $25M | |
| Accounts Payable | $2M | $705.0K | $66.0K | $750.0K | $1M | $1M | |
| Accrued Liabilities | · | $4M | $2M | $5M | $5M | $1M | |
| Current Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Capital Leases | $285.0K | $375.0K | $15.0K | $180.0K | $0 | · | |
| Other Non-current Liabilities | · | $0 | $22.0K | $0 | $7.0K | $0 | |
| Total Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Common Stock | $5.0K | $7.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-290M | $-230M | $-156M | $-121M | $-76M | $-28M | |
| AOCI | $435.0K | $23.0K | $-2.0K | $-358.0K | $-123.0K | $0 | |
| Stockholders' Equity | $160M | $212M | $108M | $129M | $167M | $-25M | |
| Liabilities + Equity | $168M | $217M | $110M | $135M | $173M | $25M | |
| Shares Outstanding | 47,766,338 | 67,255,434 | 27,699,446 | 26,567,681 | 26,567,681 | 3,418,751 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $97.0K | $0 | · | · | · | · | |
| Stock-based Comp | $8M | $6M | $13M | $7M | $4M | $707.0K | |
| Other Non-cash | $-3M | · | · | · | · | · | |
| Operating Cash Flow | $-54M | $-16M | $-21M | $-37M | $-36M | $-14M | |
| CapEx | $186.0K | $0 | $0 | · | · | · | |
| Investing Cash Flow | $3M | $-121M | $69M | $34M | $-115M | $8M | |
| Stock Issued | · | $11M | $841.0K | $0 | $149.0K | · | |
| Net Stock Activity | · | $11M | · | · | $149.0K | · | |
| Financing Cash Flow | $-21.0K | $131M | $841.0K | $0 | $177M | $5M | |
| Net Change in Cash | $-52M | $-6M | $50M | $-3M | $26M | $-736.0K | |
| Free Cash Flow | $-55M | $-20M | · | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -31.1% | -45.1% | · | -29.4% | -48.0% | · | |
| ROE | -34.6% | -34.3% | · | -34.4% | -27.6% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | · | 22.0 | 24.6 | · | |
| Quick Ratio | 14.5 | 30.6 | · | 20.3 | 22.6 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.36 | $3.15 | · | $4.84 | $6.37 | · | |
| Cash Flow / Share | $-0.80 | $-0.32 | · | $-1.42 | $-2.94 | · | |
| Cash / Share | $0.75 | $1.30 | · | $1.64 | $1.79 | · | |
| EPS (TTM) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-60M | $-74M | $-35M | $-45M | $-47M | · | |
| Market Cap | $191M | $121M | · | $98M | $274M | · | |
| P/E | -4.5 | -1.2 | -2.1 | -2.1 | -2.5 | · | |
| P/B | 1.2 | 0.6 | · | 0.8 | 1.6 | · | |
| P / Tangible Book | 1.2 | 0.6 | 0.7 | 0.8 | 1.6 | · | |
| P / Cash Flow | -3.5 | -7.8 | · | -2.6 | -7.6 | · | |
| P / FCF | -3.5 | -6.0 | · | · | · | · | |
| Earnings Yield | -22.0% | -85.0% | -48.1% | -46.9% | -40.5% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $14M | $9M | $7M | $17M | $6M | $6M | $1M | $1M | $3M | $3M | $4M | $6M | $5M | $4M | |
| SG&A Expense | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $5M | $4M | $2M | $2M | $2M | $3M | $18M | $5M | $4M | |
| Operating Expenses | $15M | $15M | $19M | $15M | $11M | $23M | $11M | $12M | $56M | $3M | $5M | $5M | $7M | $23M | $10M | $9M | |
| Operating Income | $-15M | $-15M | $-19M | $-15M | $-11M | $-23M | $-11M | $-12M | $-56M | $-3M | $-5M | $-5M | $-7M | $-23M | $-10M | $-9M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $1M | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $-934.0K | |
| Income Tax | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-13M | $-14M | $-18M | $-13M | $-9M | $-21M | $-8M | $-9M | $-55M | $-2M | $-4M | $-4M | $-5M | $-22M | $-8M | $-10M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| Shares (Basic) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| Shares (Diluted) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| EBITDA | $-15M | $-15M | · | $-15M | $-11M | $-23M | · | $-12M | $-56M | $-3M | · | $-5M | $-7M | $-23M | · | $-9M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $8M | $36M | $26M | $23M | $29M | $87M | $146M | $223M | $105M | $93M | $57M | $25M | $34M | $44M | $36M | |
| Short-term Investments | $139M | $101M | $65M | $61M | $62M | $69M | $64M | $47M | $0 | $0 | $14M | $50M | $77M | $75M | $80M | $87M | |
| Prepaid Expense | $4M | $4M | $5M | $4M | $3M | $2M | $4M | $4M | $3M | $4M | $3M | $5M | $12M | $11M | $11M | $11M | |
| Current Assets | $187M | $113M | $106M | $91M | $87M | $100M | $155M | $198M | $226M | $109M | $110M | $112M | $114M | $120M | $134M | $133M | |
| PP&E (Net) | $695.0K | $250.0K | $288.0K | $318.0K | $314.0K | · | $199.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $1M | $226.0K | $16.0K | $0 | $0 | $0 | $15.0K | $15.0K | $2M | $1M | $128.0K | $141.0K | |
| Total Assets | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Accounts Payable | $1M | $860.0K | $2M | $477.0K | $946.0K | $777.0K | $705.0K | $291.0K | $509.0K | $85.0K | $66.0K | $736.0K | $878.0K | $864.0K | $750.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | $6M | · | $3M | $3M | $3M | $2M | $2M | $2M | $4M | $5M | $4M | |
| Current Liabilities | $6M | $4M | $7M | $5M | $6M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Capital Leases | $813.0K | $216.0K | $285.0K | $352.0K | $417.0K | $319.0K | $375.0K | $0 | $0 | $0 | $15.0K | $58.0K | $100.0K | $223.0K | $180.0K | $219.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $22.0K | $34.0K | $55.0K | $87.0K | $0 | $0 | |
| Total Liabilities | $7M | $4M | $7M | $5M | $7M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-317M | $-303M | $-290M | $-272M | $-259M | $-251M | $-230M | $-221M | $-213M | $-158M | $-156M | $-152M | $-148M | $-143M | $-121M | $-113M | |
| AOCI | $-67.0K | $157.0K | $435.0K | $469.0K | $318.0K | $286.0K | $23.0K | $201.0K | $0 | $0 | $-2.0K | $-11.0K | $-35.0K | $-95.0K | $-358.0K | $-581.0K | |
| Stockholders' Equity | $240M | $148M | $160M | $177M | $186M | $193M | $212M | $219M | $222M | $106M | $108M | $110M | $113M | $117M | $129M | $134M | |
| Liabilities + Equity | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Shares Outstanding | 57,436,255 | 47,768,543 | 47,766,338 | 68,184,435 | 67,764,100 | 67,575,767 | 67,255,434 | 67,223,760 | 66,785,449 | 27,723,824 | 27,699,446 | 27,466,005 | 26,994,988 | 26,973,875 | 26,567,681 | 26,567,681 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33.0K | $38.0K | $30.0K | $29.0K | $38.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $2M | $1M | $4M | $1M | $2M | $2M | $3M | $512.0K | $465.0K | $1M | $656.0K | $777.0K | $10M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $2M | $200.0K | $700.0K | $16M | · | · | |
| Other Non-cash | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-11M | $-14M | $-16M | $-12M | $-11M | $-15M | $-6M | $-8M | $-667.0K | $-2M | $-947.0K | $3M | $-8M | $-15M | $-8M | $-4M | |
| CapEx | · | · | $0 | $109.0K | · | · | $0 | $-5M | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-57M | $-13M | $26M | $15M | $5M | $-43M | $-53M | $-72M | $-10M | $14M | $37M | $28M | $-2M | $6M | $14M | $9M | |
| Stock Issued | · | · | · | · | · | $0 | · | $2M | $9M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $15.0K | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $104M | $5.0K | $-21.0K | $0 | $0 | $0 | $41.0K | $2M | $128M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Change in Cash | $36M | $-27M | $10M | $3M | $-6M | $-58M | $-59M | $-77M | $118M | $12M | $36M | $32M | $-9M | $-9M | $8M | $3M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.2% | -7.8% | · | -6.4% | -4.1% | -13.4% | · | -5.3% | -32.1% | -1.5% | · | -3.1% | -3.9% | -15.7% | · | -6.0% | |
| ROE | -6.3% | -8.0% | · | -6.5% | -4.2% | -13.9% | · | -5.4% | -32.8% | -1.5% | · | -3.2% | -4.1% | -16.4% | · | -6.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.5 | 27.9 | · | 18.4 | 14.1 | 14.3 | · | 57.7 | 60.4 | 37.0 | · | 38.8 | 31.6 | 24.5 | · | 21.2 | |
| Quick Ratio | 30.9 | 26.9 | · | 17.6 | 13.7 | 13.9 | · | 56.5 | 59.6 | 35.6 | · | 37.0 | 28.4 | 22.3 | · | 19.5 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.17 | $3.10 | · | $2.60 | $2.74 | $2.86 | · | $3.25 | $3.33 | $3.84 | · | $4.00 | $4.17 | $4.33 | · | $5.06 | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.23 | · | · | · | $-0.07 | · | · | · | $-0.57 | · | · | |
| Cash / Share | $0.77 | $0.17 | · | $0.38 | $0.33 | $0.43 | · | $2.17 | $3.34 | $3.79 | · | $2.09 | $0.94 | $1.28 | · | $1.35 | |
| EPS (TTM) | $-0.82 | $-0.77 | · | $-0.16 | $-0.10 | $-1.78 | · | $-2.12 | $-2.14 | $-0.52 | · | $-1.66 | $-1.88 | $-2.06 | · | $0.01 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-53M | · | $-51M | $-47M | $-93M | · | $-69M | $-64M | $-15M | · | $-39M | $-45M | $-54M | · | $-48M | |
| Market Cap | $749M | $327M | · | $137M | $84M | $82M | · | $342M | $475M | $76M | · | $72M | $76M | $78M | · | $86M | |
| P/E | -15.9 | -8.9 | · | -12.6 | -12.4 | -0.7 | · | -2.4 | -3.3 | -5.3 | · | -1.6 | -1.5 | -1.4 | · | 323.0 | |
| P/B | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Tangible Book | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Cash Flow | · | -22.8 | · | · | · | -5.3 | · | · | · | -41.8 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -6.3% | -11.2% | · | -8.0% | -8.1% | -145.9% | · | -41.6% | -30.1% | -19.0% | · | -63.1% | -67.1% | -71.0% | · | 0.31% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-60M | $-74M | $-35M | $-45M | $-47M |
| EPS Dilusian | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 15.2 | 31.4 | · | 22.0 | 24.6 |
| Rasio Cepat | 14.5 | 30.6 | · | 20.3 | 22.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-55M | $-20M | · | · | · |
Pemilik institusional (13F) 116 pengaju · $682.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
116
Nilai yang dipegang
$682.3M
Posisi baru
52
Posisi yang keluar
22
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 52 (+22 vs Kuartal sebelumnya) | 22 (+14 vs Kuartal sebelumnya) | 32 (+8 vs Kuartal sebelumnya) | 19 (-4 vs Kuartal sebelumnya) | +24.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $115.026.714 | 8.821.067 | 16,86% | Saham |
| FMR LLC | $88.546.347 | 6.790.364 | 12,98% | Saham |
| UBS Group AG | $44.399.453 | 3.404.866 | 6,51% | Saham |
| BRAIDWELL LP | $36.477.770 | 2.797.375 | 5,35% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32.678.240 | 2.506.000 | 4,79% | Saham |
| BlackRock, Inc. | $30.707.531 | 2.354.872 | 4,50% | Saham |
| Cormorant Asset Management, LP | $27.462.240 | 2.106.000 | 4,02% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $25.284.808 | 1.939.019 | 3,71% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.150.448 | 1.698.654 | 3,25% | Saham |
| Woodline Partners LP | $20.633.075 | 1.582.291 | 3,02% | Saham |
| CITADEL ADVISORS LLC | $16.925.555 | 1.297.972 | 2,48% | Saham |
| Redmile Group, LLC | $15.991.343 | 1.226.330 | 2,34% | Saham |
| GREAT POINT PARTNERS LLC | $13.040.000 | 1.000.000 | 1,91% | Saham |
| Affinity Asset Advisors, LLC | $12.674.880 | 972.000 | 1,86% | Saham |
| MILLENNIUM MANAGEMENT LLC | $11.842.902 | 908.198 | 1,74% | Saham |
| ADAR1 Capital Management, LLC | $10.727.343 | 822.649 | 1,57% | Saham |
| Driehaus Capital Management LLC | $10.301.600 | 790.000 | 1,51% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $10.202.039 | 782.199 | 1,50% | Saham |
| STEMPOINT CAPITAL LP | $9.685.395 | 742.745 | 1,42% | Saham |
| STATE STREET CORP | $8.955.507 | 686.772 | 1,31% | Saham |
| AMERIPRISE FINANCIAL INC | $8.579.978 | 657.971 | 1,26% | Saham |
| Parkman Healthcare Partners LLC | $7.347.831 | 563.484 | 1,08% | Saham |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6.794.909 | 521.082 | 1,00% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $6.308.061 | 483.747 | 0,92% | Saham |
| VANGUARD GROUP INC | $5.362.016 | 1.340.504 | 0,79% | Saham |
| Invesco Ltd. | $4.869.724 | 373.445 | 0,71% | Saham |
| MORGAN STANLEY | $4.760.747 | 365.088 | 0,70% | Saham |
| NAN FUNG TRINITY (HK) LTD | $4.702.928 | 360.654 | 0,69% | Saham |
| NORTHERN TRUST CORP | $4.306.981 | 330.290 | 0,63% | Saham |
| Ikarian Capital, LLC | $3.912.000 | 300.000 | 0,57% | Saham |
| TD Asset Management Inc | $3.483.010 | 267.102 | 0,51% | Saham |
| Qube Research & Technologies Ltd | $3.477.103 | 266.649 | 0,51% | Saham |
| Ally Bridge Group (NY) LLC | $3.249.203 | 249.172 | 0,48% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.125.127 | 239.657 | 0,46% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $3.123.319 | 239.451 | 0,46% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.543.335 | 195.041 | 0,37% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $2.512.808 | 192.700 | 0,37% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.381.691 | 182.645 | 0,35% | Saham |
| FIFTH THIRD BANCORP | $2.150.596 | 164.923 | 0,32% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.147.844 | 164.712 | 0,31% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.933.024 | 148.238 | 0,28% | Saham |
| JANE STREET GROUP, LLC | $1.718.163 | 131.761 | 0,25% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.699.112 | 130.300 | 0,25% | Saham |
| ArchPoint Investors | $1.680.856 | 128.900 | 0,25% | Saham |
| Schonfeld Strategic Advisors LLC | $1.644.838 | 126.138 | 0,24% | Saham |
| Bank of New York Mellon Corp | $1.612.501 | 123.658 | 0,24% | Saham |
| KOTLER KEVIN | $1.600.000 | 400.000 | 0,23% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.364.427 | 104.634 | 0,20% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.262.364 | 96.807 | 0,19% | Saham |
| Nuveen, LLC | $1.120.592 | 85.935 | 0,16% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund III, L.P. ×11 pengajuan | 7 Juli 2026 | 33,00% | Amandemen | Kampanye dewan | SEC |
| AI ETI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×6 pengajuan | 16 Okt. 2025 | 0,00% | Amandemen | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 21 orang dalam · 10 pejabat · 13 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Aoife Brennan | President and CEO | 27 Juni 2026 M | 87.731 | 0 | 1 | $-406.979 |
| Robert Azelby | President & CEO | 31 Okt. 2022 A | · | 0 | 0 | $0 |
| Susan Altschuller | Chief Financial Officer | 6 Jan. 2026 A | · | 0 | 0 | $0 |
| Erin Lavelle | COO & CFO | 31 Okt. 2022 A | · | 0 | 0 | $0 |
| Brett Kaplan | Chief Operating Officer | 26 Agu 2024 A | · | 0 | 0 | $0 |
| Perrin Megan Wilson | Chief Business Officer | 6 Jan. 2026 A | · | 0 | 0 | $0 |
| Cindy Driscoll | Senior Vice President, Finance | 6 Jan. 2026 A | · | 0 | 0 | $0 |
| Emily Pimblett | SVP, Finance & CAO | 18 Juni 2025 M | 18.888 | 0 | 0 | $0 |
| Valerie Morisset | EVP, R&D AND CSO | 22 Juli 2024 S | 31.317 | 0 | 0 | $0 |
| James B Bucher | EVP and General Counsel | 31 Okt. 2022 A | · | 0 | 0 | $0 |
| Stephen Basil Thomas | Direktur | 15 Sep. 2026 S | 467.969 | 0 | 5 | $-2.245.963 |
| Breanna Maurine Celebi | Direktur | 29 Juni 2026 A | · | 0 | 0 | $0 |
| Andrew David Levin | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Judith Dunn | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Alexander Cumbo | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Kimberlee C Drapkin | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Douglas E Williams | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Simon Tate | Direktur | 26 Juni 2024 A | · | 0 | 0 | $0 |
| Adam Joseph Rosenberg | Direktur | 26 Juni 2024 A | · | 0 | 0 | $0 |
| Liam Ratcliffe | Direktur | 26 Juni 2024 A | · | 0 | 0 | $0 |
| Leone D Patterson | Direktur | 19 Mei 2022 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 19 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,05% | 372.681 SH | 1 Okt. 2026 | Harian |
| VAMO · Cambria ETF Trust | 0,84% | 76.753 NS | 31 Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,70% | 27.171 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,12% | 119.861 SH | 11 Sep. 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,11% | 133.441 NS | 31 Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 17.165 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 914.481 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,02% | 145.416 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 16.764 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 202.877 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.698 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 76.929 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.520 SH | 8 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 8.176 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 13.817 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 292.463 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.366.686 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.917 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 195.031 SH | 11 Sep. 2026 | Harian |
CLYM Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 21 analis
BELI
Target median
$26.50
+142,2%
10 47,6%
Beli Kuat
10 47,6%
Beli
1 4,8%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
14 analis · 2026-09-20Target rata-rata $27.57 +152,0%
← Di bawah semua target
Harga saat ini $10.94
Rendah$18.00
Rata-rata$27.57
Tinggi$40.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026